143 related articles for article (PubMed ID: 19066260)
1. US psychiatrist is fired from radio programme for not disclosing drug company ties.
Tanne JH
BMJ; 2008 Dec; 337():a2934. PubMed ID: 19066260
[No Abstract] [Full Text] [Related]
2. 'Interests' in medicine and the inadequacy of disclosure.
Kerridge I
Aust N Z J Psychiatry; 2012 Jun; 46(6):501-3. PubMed ID: 22679203
[No Abstract] [Full Text] [Related]
3. US university psychiatrist loses chairmanship over drug company payments.
Tanne JH
BMJ; 2009 Jan; 338():a3188. PubMed ID: 19126618
[No Abstract] [Full Text] [Related]
4. Supping with the devil? The dangers of liaisons between pharma and our profession.
Boyce P; Malhi GS
Aust N Z J Psychiatry; 2012 Jun; 46(6):493-4. PubMed ID: 22679200
[No Abstract] [Full Text] [Related]
5. Key opinion leaders in psychiatry: a conflicted pathway to career advancement.
Jureidini J
Aust N Z J Psychiatry; 2012 Jun; 46(6):495-7. PubMed ID: 22679201
[No Abstract] [Full Text] [Related]
6. Why I declined an invitation to a drug company seminar.
Khan MM
BMJ; 2007 Oct; 335(7625):887. PubMed ID: 17962290
[No Abstract] [Full Text] [Related]
7. [Relationship of psychiatrists to the pharmaceutical companies--part of, or the solution to, the problem].
Insel TR
Lege Artis Med; 2010 Sep; 20(9):630-1. PubMed ID: 21469310
[No Abstract] [Full Text] [Related]
8. Three quarters of guideline panellists have ties to the drug industry.
Torjesen I
BMJ; 2013 Aug; 347():f4998. PubMed ID: 23945363
[No Abstract] [Full Text] [Related]
9. For richer, for poorer, in sickness and in health: the entanglement of science and marketing.
Smith GP
Aust N Z J Psychiatry; 2012 Jun; 46(6):498-500. PubMed ID: 22679202
[No Abstract] [Full Text] [Related]
10. The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
Rivkees SA
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):607-9. PubMed ID: 18780592
[No Abstract] [Full Text] [Related]
11. Financial relationships between research and pharmaceutical/biotech companies: disclosure is imperative.
Caughey AB; Urato AC
Am J Obstet Gynecol; 2007 Jan; 196(1):e13; author reply e13-4; discussion e14. PubMed ID: 16959207
[No Abstract] [Full Text] [Related]
12. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
Quan SF
J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
[No Abstract] [Full Text] [Related]
13. Doctors and drug companies.
Blumenthal D
N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
[No Abstract] [Full Text] [Related]
14. US Senate committee investigates conflicts of interest in industry funded medical education.
Tanne JH
BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162
[No Abstract] [Full Text] [Related]
15. Conflict of interest in the physician interface with the biomedical industry.
Minnigan H; Chisholm CD
Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the commercial-academic interface.
Drazen JM
N Engl J Med; 2015 May; 372(19):1853-4. PubMed ID: 25946285
[No Abstract] [Full Text] [Related]
17. US psychiatrist steps down after questions about drug company payments.
Hopkins Tanne J
BMJ; 2008 Oct; 337():a2088. PubMed ID: 18927175
[No Abstract] [Full Text] [Related]
18. [Conflict of interest viewed from over-sea reports regarding relationship between clinical psychiatry and drug industry].
Senba J
Seishin Shinkeigaku Zasshi; 2010; 112(11):1124-9. PubMed ID: 21351692
[No Abstract] [Full Text] [Related]
19. Physician-industry relations--will fewer gifts make a difference?
Steinbrook R
N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
[No Abstract] [Full Text] [Related]
20. Answering Brody's challenge from a pharmapologist perspective.
Harter TD
Am J Bioeth; 2011 Jan; 11(1):29-30. PubMed ID: 21240803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
